Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-12-10
pubmed:abstractText
To assess whether cilostazol, a phosphodiesterase III inhibitor, improves treadmill and community-based walking ability and health-related quality of life (HQL) in patients with intermittent claudication resulting from peripheral arterial disease (PAD).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0002-8614
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1939-46
pubmed:dateRevised
2008-3-10
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
pubmed:affiliation
Department of Medicine, Division of Internal Medicine and Cardiology, The University of Colorado Health Sciences Center, Denver 80262, USA. judy.regensteiner@uchsc.edu
pubmed:publicationType
Journal Article, Meta-Analysis